Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus," NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.
加利福尼亞州雷德伍德城，2024年11月27日（GLOBE NEWSWIRE）——Coherus BioSciences, Inc.（「Coherus」，納斯達克股票代碼：CHRS）今天宣佈，高級管理層將參加2024年花旗全球醫療大會，首席開發官特蕾莎·拉瓦利博士將於美國東部時間2024年12月3日下午3點15分參加腫瘤學新機制小組。
The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: .
小組討論將通過Coherus網站 「投資者活動和演示」 部分的鏈接通過網絡直播觀看:.
Coherus Contact Information:
For Investors:
Jodi Sievers
VP, Investor Relations & Corporate Communications
IR@coherus.com
Coherus 聯繫信息：
對於投資者：
喬迪·西弗斯
投資者關係與企業傳播副總裁
IR@coherus.com
